Valuation (45%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.46 | N/A |
| PEG Ratio (TTM) | -1.34 | N/A |
| P/S Ratio (TTM) | 1.28 | N/A |
| P/B Ratio (TTM) | 0.77 | N/A |
| P/FCF Ratio (TTM) | -4.41 | N/A |
| Price to 5YR AVG Earnings Ratio | 20.41 | N/A |
| Price to 5YR AVG FCF Ratio | -2.93 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.75% | N/A |
| ROE (TTM) | 7.48% | N/A |
| Net Profit Margin (TTM) | 26.18% | N/A |
| ROIC 5YR AVG | -4.56% | N/A |
Growth (92%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 173.77% | 383.81% | 333.79% |
| Revenue | 84.25% | 101.92% | 124.14% |
| Net Income | 180.92% | 395.23% | 216.75% |
| Cash Flow | -91.62% | 31.62% | 29.09% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.95 | N/A |
| Quick Ratio (TTM) | 1.00 | N/A |
| D/E Ratio (TTM) | 0.75 | N/A |
| Interest Coverage (TTM) | 8.11 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.31 | N/A |
| LTL to 5YR AVG FCF | -8.05 | N/A |
| Shares Outstanding Growth 5YR AVG | 26.86% | N/A |